{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:01:32Z","timestamp":1789740092517,"version":"4.0.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-026-04644-3","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T01:06:24Z","timestamp":1782867984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Performance of the cervical cancer screening program in Souss-Massa, Morocco: evidence for strategic transition toward HPV testing"],"prefix":"10.1186","volume":"26","author":[{"given":"Bouchra","family":"Amaoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chafika","family":"Belkadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryem","family":"Dlhane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Amrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Ammari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Safini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef Chami","family":"Khazraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdellatif","family":"Benider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanae","family":"Abaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slimane","family":"Semghouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"11","key":"4644_CR1","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","volume":"87","author":"FX Bosch","year":"1995","unstructured":"Bosch FX, Manos MM, Mu\u00f1oz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst. 1995;87(11):796\u2013802. https:\/\/doi.org\/10.1093\/jnci\/87.11.796.","journal-title":"J Natl Cancer Inst"},{"issue":"9590","key":"4644_CR2","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","volume":"370","author":"M Schiffman","year":"2007","unstructured":"Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370(9590):890\u2013907.","journal-title":"Lancet"},{"issue":"4","key":"4644_CR3","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/jcp.55.4.244","volume":"55","author":"FX Bosch","year":"2002","unstructured":"Bosch FX, Lorincz A, Mu\u00f1oz N, Meijer CJLM, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55(4):244\u201365.","journal-title":"J Clin Pathol"},{"key":"4644_CR4","doi-asserted-by":"publisher","first-page":"100170","DOI":"10.1016\/j.pvr.2019.100170","volume":"8","author":"K Canfell","year":"2019","unstructured":"Canfell K. Towards the global elimination of cervical cancer. Papillomavirus Res. 2019;8:100170.","journal-title":"Papillomavirus Res"},{"key":"4644_CR5","unstructured":"World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. 2nd ed. World Health Organ; 2021. https:\/\/iris.who.int\/handle\/10665\/342365."},{"issue":"1","key":"4644_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/ijgo.13458","volume":"152","author":"DB Vale","year":"2021","unstructured":"Vale DB, Teixeira JC, Bragan\u00e7a JF, Derchain S, Sarian LO, Zeferino LC. Elimination of cervical cancer in low- and middle-income countries: inequality of access and fragile healthcare systems. Int J Gynaecol Obstet. 2021;152(1):7\u201311.","journal-title":"Int J Gynaecol Obstet"},{"key":"4644_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.pvr.2019.04.011","volume":"7","author":"M Arbyn","year":"2019","unstructured":"Arbyn M, Gravitt P, Snijders PJF, Meijer CJLM. What is needed now for successful scale-up of screening? Papillomavirus Res. 2019;7:173\u20135.","journal-title":"Papillomavirus Res"},{"issue":"3","key":"4644_CR8","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4644_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ygyno.2021.10.073","volume":"164","author":"C Chargari","year":"2022","unstructured":"Chargari C, Arbyn M, Leary A, Abu-Rustum NR, Basu P, Bray F, et al. Increasing global accessibility to high-level treatments for cervical cancers. Gynecol Oncol. 2022;164(1):231\u201341.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"4644_CR10","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1200\/JGO.2016.006577","volume":"3","author":"J Jeronimo","year":"2017","unstructured":"Jeronimo J, Castle PE, Temin S, Denny L, Gupta V, Kim JJ, et al. Secondary prevention of cervical cancer: ASCO resource-stratified clinical practice guideline. J Glob Oncol. 2017;3(5):635\u201357.","journal-title":"J Glob Oncol"},{"issue":"2","key":"4644_CR11","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1001\/amajethics.2020.126","volume":"22","author":"W Gossa","year":"2020","unstructured":"Gossa W, Fetters MD. How should cervical cancer prevention be improved in LMICs? AMA J Ethics. 2020;22(2):126\u201334.","journal-title":"AMA J Ethics"},{"key":"4644_CR12","unstructured":"Ministry of Health and Social Protection. Cancer Registry of the Greater Casablanca Region 2018\u20132021. https:\/\/www.contrelecancer.ma. Accessed 15 May 2025."},{"key":"4644_CR13","unstructured":"Cancer Registry of the Greater Casablanca Region. Incidence Report 2013\u20132017. Lalla Salma Foundation for Cancer Prevention and Treatment; 2021. https:\/\/www.contrelecancer.ma. Accessed 25 Apr 2025."},{"key":"4644_CR14","unstructured":"Ministry of Health. National Plan for Cancer Prevention and Control 2020\u20132029. Rabat: Ministry of Health; 2021. https:\/\/www.sante.gov.ma. Accessed 1 June 2025."},{"key":"4644_CR15","unstructured":"Ministry of Health. Breast and Cervical Cancer Screening Program in Morocco. https:\/\/www.contrelecancer.ma.\u00a0 Accessed 22 June 2025."},{"issue":"2","key":"4644_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.radmp.2024.04.001","volume":"5","author":"B Amaoui","year":"2024","unstructured":"Amaoui B, Semghouli S, El Kacemi H, Lalya I, Benchekroune N, Safini F, et al. Survey of current practices in the management of cervical cancer by Moroccan radiotherapists. Radiat Med Prot. 2024;5(2):124\u201330.","journal-title":"Radiat Med Prot"},{"key":"4644_CR17","volume-title":"General Population and Housing Census 2024: Souss-Massa Region","author":"High Commission for Planning","year":"2024","unstructured":"High Commission for Planning. General Population and Housing Census 2024: Souss-Massa Region. Rabat: Kingdom of Morocco; 2024."},{"key":"4644_CR18","doi-asserted-by":"publisher","first-page":"b2393","DOI":"10.1136\/bmj.b2393","volume":"338","author":"JAC Sterne","year":"2009","unstructured":"Sterne JAC, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393.","journal-title":"BMJ"},{"key":"4644_CR19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1471-2288-13-92","volume":"13","author":"L Thabane","year":"2013","unstructured":"Thabane L, Mbuagbaw L, Zhang S, Samaan Z, Marcucci M, Ye C, et al. A tutorial on sensitivity analyses in clinical trials: the what, why, when and how. BMC Med Res Methodol. 2013;13:92.","journal-title":"BMC Med Res Methodol"},{"key":"4644_CR20","volume-title":"Global strategy to accelerate the elimination of cervical cancer as a public health problem","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: WHO; 2020."},{"issue":"3","key":"4644_CR21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1177\/0969141318824627","volume":"26","author":"F Selmouni","year":"2019","unstructured":"Selmouni F, Belakhel L, Sauvaget C, Abousselham L, Lucas E, Muwonge R, et al. Evaluation of the national cervical cancer screening program in Morocco: achievements and challenges. J Med Screen. 2019;26(3):162\u20137.","journal-title":"J Med Screen"},{"issue":"8","key":"4644_CR22","doi-asserted-by":"publisher","first-page":"e1115","DOI":"10.1016\/S2214-109X(22)00241-8","volume":"10","author":"L Bruni","year":"2022","unstructured":"Bruni L, Serrano B, Roura E, Alemany L, Cowan M, Herrero R, et al. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis. Lancet Glob Health. 2022;10(8):e1115\u201327.","journal-title":"Lancet Glob Health"},{"issue":"15","key":"4644_CR23","first-page":"6721","volume":"16","author":"B Chumworathayi","year":"2015","unstructured":"Chumworathayi B, Srisupundit K, Therasakvichya S. The impact of mobile units on cervical cancer screening in Thailand: from 19.9% to 70.1% over six years. Asian Pac J Cancer Prev. 2015;16(15):6721\u20136.","journal-title":"Asian Pac J Cancer Prev"},{"key":"4644_CR24","unstructured":"International Papillomavirus Society. Global challenges in HPV screening implementation: cultural and educational barriers. IPVS Policy Brief; 2021. https:\/\/ipvsoc.org\/why-join-ipvc\/. Accessed 20 Mar 2025."},{"issue":"10","key":"4644_CR25","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1177\/09564624211007260","volume":"32","author":"P Kakani","year":"2021","unstructured":"Kakani P, Kojima N, Banda BA, Lewis S, Suri R, Chibwana F, et al. Increasing cervical cancer screening at a non-government medical center in Lilongwe, Malawi. Int J STD AIDS. 2021;32(10):933\u20139.","journal-title":"Int J STD AIDS"},{"issue":"12","key":"4644_CR26","doi-asserted-by":"publisher","first-page":"e1605","DOI":"10.1016\/S2214-109X(19)30423-1","volume":"7","author":"S Krivacsy","year":"2019","unstructured":"Krivacsy S, Bayingana A, Binagwaho A. Affordable human papillomavirus screening needed to eradicate cervical cancer for all. Lancet Glob Health. 2019;7(12):e1605\u20136.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"4644_CR27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12992-019-0489-3","volume":"15","author":"NT Tran","year":"2019","unstructured":"Tran NT, Taylor R, Choe SI, Pyo HS, Kim YA, So HC. Mobile health initiatives in LMICs: a systematic review of effectiveness. Global Health. 2019;15(1):49.","journal-title":"Global Health"},{"key":"4644_CR28","first-page":"843557","volume":"12","author":"PN Abotchie","year":"2022","unstructured":"Abotchie PN, Shokar NK. Cervical cancer screening among immigrant women: barriers and facilitators. Front Oncol. 2022;12:843557.","journal-title":"Front Oncol"},{"key":"4644_CR29","unstructured":"Rapport National SIDA 2024 Maroc. Morocco: Ministry of Health and Social Protection; 2024. Available from: https:\/\/www.sante.gov.ma\/Documents\/2024\/11\/Rapport%20SIDA%202024%20VF%20.pdf."},{"issue":"2","key":"4644_CR30","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1016\/S2214-109X(20)30459-9","volume":"9","author":"D Telzle","year":"2021","unstructured":"Telzle D, Tanaka LF, Lee KK, Khalil AI, Baussano I, Shah ASV, et al. Estimates of the global burden of HIV-associated cervical cancer. Lancet Glob Health. 2021;9(2):e161\u20139. https:\/\/doi.org\/10.1016\/S2214-109X(20)30459-9.","journal-title":"Lancet Glob Health"},{"issue":"3","key":"4644_CR31","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.3892\/ol.2020.11754","volume":"20","author":"R Hull","year":"2020","unstructured":"Hull R, Mbele M, Makhafola T, Hicks C, Wang S, Reis R, et al. Cervical cancer in low- and middle-income countries: a review. Oncol Lett. 2020;20(3):2058\u201374.","journal-title":"Oncol Lett"},{"key":"4644_CR32","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12889-023-15239-0","volume":"23","author":"Y Ouedraogo","year":"2023","unstructured":"Ouedraogo Y, Zi\u00e9 B, Kambou M, et al. Disparities in cervical cancer screening between urban and rural settings in West Africa. BMC Public Health. 2023;23:334.","journal-title":"BMC Public Health"},{"issue":"3","key":"4644_CR33","first-page":"494","volume":"141","author":"C Sauvaget","year":"2017","unstructured":"Sauvaget C, Sankaranarayanan R, Badwe R, et al. Challenges in organizing cervical cancer screening programmes in low-resource settings. Int J Cancer. 2017;141(3):494\u2013500.","journal-title":"Int J Cancer"},{"issue":"7","key":"4644_CR34","first-page":"1153","volume":"150","author":"F Ben Ayed","year":"2022","unstructured":"Ben Ayed F, Trabelsi I, Ben Abderrahim M, et al. Cervical screening in North Africa: a comparative analysis. Int J Cancer. 2022;150(7):1153\u201362.","journal-title":"Int J Cancer"},{"issue":"3","key":"4644_CR35","first-page":"e161","volume":"4","author":"N Mwangome","year":"2022","unstructured":"Mwangome N, Gatungu D, Njeru R, et al. Text message reminders improve screening uptake in low-income settings: a Kenyan cluster randomized trial. Lancet Digit Health. 2022;4(3):e161\u201370.","journal-title":"Lancet Digit Health"},{"issue":"3","key":"4644_CR36","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ijgo.2015.07.024","volume":"132","author":"RA Mustafa","year":"2016","unstructured":"Mustafa RA, Santesso N, Khatib R, Mustafa AA, Wiercioch W, Kehar R, et al. Accuracy of HPV tests, VIA, cytology, and colposcopy: systematic reviews and meta-analyses. Int J Gynaecol Obstet. 2016;132(3):259\u201365.","journal-title":"Int J Gynaecol Obstet"},{"issue":"9","key":"4644_CR37","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.jiph.2020.06.012","volume":"13","author":"DA Obeid","year":"2020","unstructured":"Obeid DA, Almatrrouk SA, Alfageeh MB, Al-Ahdal MNA, Alhamlan FS. HPV epidemiology in populations with normal or abnormal cervical cytology or cancer in the Middle East and North Africa: a systematic review and meta-analysis. J Infect Public Health. 2020;13(9):1304\u201313.","journal-title":"J Infect Public Health"},{"issue":"11","key":"4644_CR38","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1080\/13696998.2019.1624556","volume":"22","author":"W Messoudi","year":"2019","unstructured":"Messoudi W, Elmahi T, Nejjari C, Tachfouti N, Zidouh A, Saadani G, et al. Cervical cancer prevention in Morocco: a model-based cost-effectiveness analysis. J Med Econ. 2019;22(11):1153\u20139. https:\/\/doi.org\/10.1080\/13696998.2019.1624556.","journal-title":"J Med Econ"},{"issue":"7","key":"4644_CR39","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.7314\/APJCP.2012.13.7.3159","volume":"13","author":"M Berraho","year":"2012","unstructured":"Berraho M, Najdi A, Mathoulin-Pelissier S, Salamon R, Nejjari C. Direct costs of cervical cancer management in Morocco. Asian Pac J Cancer Prev. 2012;13(7):3159\u201363.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"4644_CR40","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/ijc.30695","volume":"141","author":"AK Mezei","year":"2017","unstructured":"Mezei AK, Armstrong HL, Pedersen HN, Campos NG, Mitchell SM, Sekikubo M, et al. Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: a systematic review. Int J Cancer. 2017;141(3):437\u201346.","journal-title":"Int J Cancer"},{"key":"4644_CR41","unstructured":"World Health Organization. Global partners cheer progress towards eliminating cervical cancer and underline challenges. Geneva: World Health Organization; 2023. Available from: https:\/\/www.who.int\/news\/item\/17-11-2023-global-partners-cheer-progress-towards-eliminating-cervical-cancer-and-underline-challenges."},{"key":"4644_CR42","doi-asserted-by":"publisher","first-page":"20761","DOI":"10.1038\/s41598-024-71735-2","volume":"14","author":"AGM Da Costa","year":"2024","unstructured":"Da Costa AGM, de Almeida LMN, Toscano MLR, da Silva BMF, de Almeida JCG, de Almeida LM, et al. Transition from opportunistic to organized screening with DNA-HPV testing detected prevalent cervical cancers 10 years in advance. Sci Rep. 2024;14:20761.","journal-title":"Sci Rep"},{"issue":"2","key":"4644_CR43","first-page":"181","volume":"320","author":"GS Ogilvie","year":"2018","unstructured":"Ogilvie GS, van Niekerk DJ, Krajden M, et al. Effect of self-collected HPV testing on participation in cervical cancer screening: a community-based randomized controlled trial. JAMA. 2018;320(2):181\u201390.","journal-title":"JAMA"},{"key":"4644_CR44","first-page":"e2300123","volume":"9","author":"T Diop","year":"2023","unstructured":"Diop T, Ndiaye M, Thiam A, et al. Public-private partnerships for cervical screening: lessons from Senegal. JCO Glob Oncol. 2023;9:e2300123.","journal-title":"JCO Glob Oncol"},{"issue":"2\u20133","key":"4644_CR45","doi-asserted-by":"publisher","first-page":"102304","DOI":"10.1016\/j.admp.2024.102304","volume":"85","author":"J Turki","year":"2024","unstructured":"Turki J, Karboul S, Kasbaoui R, Ouerfelli N, Marnaoui M. Cervical cancer prevention: the decisive impact of occupational medicine. Ann Med Pharm. 2024;85(2\u20133):102304. https:\/\/doi.org\/10.1016\/j.admp.2024.102304.","journal-title":"Ann Med Pharm"},{"key":"4644_CR46","doi-asserted-by":"publisher","unstructured":"Mon HM, Robb KA, Demou E. Effectiveness of workplace cancer screening interventions: a systematic review. BMC Cancer. 2024;24(1):999. https:\/\/doi.org\/10.1186\/s12885-024-12649-0.","DOI":"10.1186\/s12885-024-12649-0"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-026-04644-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-026-04644-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-026-04644-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:02:16Z","timestamp":1789736536000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12905-026-04644-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4644"],"URL":"https:\/\/doi.org\/10.1186\/s12905-026-04644-3","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All protocols associated with this study were approved by the ethics committee of the Faculty of Medicine and Pharmacy in Agadir. The researchers did not have direct contact with the patients or access to their medical records. All data used were entirely anonymous and were collected in strict accordance with applicable ethical standards. I confirm that the study was conducted in strict accordance with the principles set out in the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"464"}}